Rank | Gene Set | Z-score |
---|---|---|
1 | gamma-aminobutyric acid transport (GO:0015812) | 8.63183485 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.81016341 |
3 | L-phenylalanine catabolic process (GO:0006559) | 4.81016341 |
4 | endocardial cushion morphogenesis (GO:0003203) | 4.74808522 |
5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.63601120 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.45759374 |
7 | behavioral response to nicotine (GO:0035095) | 4.42691586 |
8 | sodium-independent organic anion transport (GO:0043252) | 4.38911434 |
9 | L-phenylalanine metabolic process (GO:0006558) | 4.37071947 |
10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.37071947 |
11 | aromatic amino acid family catabolic process (GO:0009074) | 4.31635670 |
12 | urea cycle (GO:0000050) | 4.21228687 |
13 | urea metabolic process (GO:0019627) | 4.21228687 |
14 | cAMP catabolic process (GO:0006198) | 4.13804704 |
15 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.13177783 |
16 | complement activation, alternative pathway (GO:0006957) | 4.12545866 |
17 | regulation of protein activation cascade (GO:2000257) | 4.10667716 |
18 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.97394863 |
19 | mesenchyme morphogenesis (GO:0072132) | 3.97070218 |
20 | kynurenine metabolic process (GO:0070189) | 3.94925713 |
21 | bile acid biosynthetic process (GO:0006699) | 3.94051248 |
22 | tryptophan catabolic process (GO:0006569) | 3.91140856 |
23 | indole-containing compound catabolic process (GO:0042436) | 3.91140856 |
24 | indolalkylamine catabolic process (GO:0046218) | 3.91140856 |
25 | regulation of complement activation (GO:0030449) | 3.90663593 |
26 | protein carboxylation (GO:0018214) | 3.86708741 |
27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86708741 |
28 | cardiac right ventricle morphogenesis (GO:0003215) | 3.76741014 |
29 | tryptophan metabolic process (GO:0006568) | 3.75636711 |
30 | high-density lipoprotein particle remodeling (GO:0034375) | 3.73893707 |
31 | cyclic nucleotide catabolic process (GO:0009214) | 3.72903134 |
32 | Notch signaling involved in heart development (GO:0061314) | 3.71286263 |
33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.66661308 |
34 | nitrogen cycle metabolic process (GO:0071941) | 3.66429540 |
35 | negative regulation of fibrinolysis (GO:0051918) | 3.65423294 |
36 | intestinal epithelial cell development (GO:0060576) | 3.60132016 |
37 | reverse cholesterol transport (GO:0043691) | 3.58379620 |
38 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.56407417 |
39 | regulation of fibrinolysis (GO:0051917) | 3.54629875 |
40 | cellular hyperosmotic response (GO:0071474) | 3.52822276 |
41 | phospholipid homeostasis (GO:0055091) | 3.51895281 |
42 | glyoxylate metabolic process (GO:0046487) | 3.46076982 |
43 | bile acid metabolic process (GO:0008206) | 3.42002493 |
44 | cysteine metabolic process (GO:0006534) | 3.41798018 |
45 | cholesterol efflux (GO:0033344) | 3.39734560 |
46 | glutamate metabolic process (GO:0006536) | 3.39276361 |
47 | plasma lipoprotein particle clearance (GO:0034381) | 3.38875090 |
48 | phospholipid efflux (GO:0033700) | 3.37133393 |
49 | regulation of triglyceride catabolic process (GO:0010896) | 3.35137196 |
50 | plasma lipoprotein particle remodeling (GO:0034369) | 3.32534627 |
51 | protein-lipid complex remodeling (GO:0034368) | 3.32534627 |
52 | macromolecular complex remodeling (GO:0034367) | 3.32534627 |
53 | triglyceride homeostasis (GO:0070328) | 3.30294400 |
54 | acylglycerol homeostasis (GO:0055090) | 3.30294400 |
55 | regulation of cholesterol homeostasis (GO:2000188) | 3.28899106 |
56 | lysine catabolic process (GO:0006554) | 3.26848771 |
57 | lysine metabolic process (GO:0006553) | 3.26848771 |
58 | sulfur amino acid catabolic process (GO:0000098) | 3.24373742 |
59 | homocysteine metabolic process (GO:0050667) | 3.21144075 |
60 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.20551082 |
61 | negative regulation of sterol transport (GO:0032372) | 3.19737577 |
62 | negative regulation of cholesterol transport (GO:0032375) | 3.19737577 |
63 | plasma lipoprotein particle assembly (GO:0034377) | 3.18559166 |
64 | interkinetic nuclear migration (GO:0022027) | 3.15318049 |
65 | negative regulation of hormone metabolic process (GO:0032351) | 3.10956365 |
66 | bile acid and bile salt transport (GO:0015721) | 3.09480634 |
67 | nephron tubule formation (GO:0072079) | 3.09112136 |
68 | positive regulation of lipid catabolic process (GO:0050996) | 3.08964335 |
69 | tyrosine metabolic process (GO:0006570) | 3.07326384 |
70 | cGMP biosynthetic process (GO:0006182) | 3.03671665 |
71 | protein-lipid complex assembly (GO:0065005) | 3.02168810 |
72 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.96049970 |
73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.93402338 |
74 | potassium ion import (GO:0010107) | 2.93094716 |
75 | cellular response to ATP (GO:0071318) | 2.92394891 |
76 | inositol phosphate-mediated signaling (GO:0048016) | 2.90693788 |
77 | amino-acid betaine metabolic process (GO:0006577) | 2.90577207 |
78 | auditory receptor cell differentiation (GO:0042491) | 2.89696414 |
79 | lipoprotein transport (GO:0042953) | 2.88969379 |
80 | somite rostral/caudal axis specification (GO:0032525) | 2.88598569 |
81 | glomerulus development (GO:0032835) | 2.87441996 |
82 | aromatic amino acid family metabolic process (GO:0009072) | 2.86589726 |
83 | heart valve morphogenesis (GO:0003179) | 2.85812308 |
84 | metanephric mesenchyme development (GO:0072075) | 2.85301927 |
85 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.85299583 |
86 | alpha-amino acid catabolic process (GO:1901606) | 2.84820417 |
87 | midgut development (GO:0007494) | 2.83489563 |
88 | plasma lipoprotein particle organization (GO:0071827) | 2.80546121 |
89 | regulation of cholesterol esterification (GO:0010872) | 2.80433838 |
90 | lipoprotein metabolic process (GO:0042157) | 2.80019667 |
91 | negative regulation of protein activation cascade (GO:2000258) | 2.78530312 |
92 | sterol homeostasis (GO:0055092) | 2.76866091 |
93 | cellular glucuronidation (GO:0052695) | 2.76741737 |
94 | cytolysis (GO:0019835) | 2.76394946 |
95 | cholesterol homeostasis (GO:0042632) | 2.76092295 |
96 | regulation of bile acid biosynthetic process (GO:0070857) | 2.74613547 |
97 | protein-lipid complex subunit organization (GO:0071825) | 2.73481595 |
98 | ethanol oxidation (GO:0006069) | 2.73025875 |
99 | negative regulation of DNA repair (GO:0045738) | 2.70835056 |
100 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.70329728 |
101 | cellular modified amino acid catabolic process (GO:0042219) | 2.68446127 |
102 | aorta morphogenesis (GO:0035909) | 2.67587411 |
103 | toxin metabolic process (GO:0009404) | 2.66702773 |
104 | indolalkylamine metabolic process (GO:0006586) | 2.66689698 |
105 | low-density lipoprotein particle clearance (GO:0034383) | 2.66054474 |
106 | coenzyme catabolic process (GO:0009109) | 2.64351906 |
107 | negative regulation of lipase activity (GO:0060192) | 2.63997593 |
108 | renal tubule morphogenesis (GO:0061333) | 2.63973098 |
109 | serine family amino acid catabolic process (GO:0009071) | 2.62977397 |
110 | complement activation, classical pathway (GO:0006958) | 2.62655079 |
111 | fibrinolysis (GO:0042730) | 2.62528777 |
112 | complement activation (GO:0006956) | 2.61849773 |
113 | cellular amino acid catabolic process (GO:0009063) | 2.60995892 |
114 | heart valve formation (GO:0003188) | 2.60607832 |
115 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 2.60423468 |
116 | exogenous drug catabolic process (GO:0042738) | 2.58860712 |
117 | cellular ketone body metabolic process (GO:0046950) | 2.58717323 |
118 | drug catabolic process (GO:0042737) | 2.58704840 |
119 | low-density lipoprotein particle remodeling (GO:0034374) | 2.58703612 |
120 | regulation of cholesterol storage (GO:0010885) | 2.58112780 |
121 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.58003137 |
122 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.58003137 |
123 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.58003137 |
124 | basic amino acid transport (GO:0015802) | 2.57675517 |
125 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.57156962 |
126 | cGMP metabolic process (GO:0046068) | 2.56084299 |
127 | epoxygenase P450 pathway (GO:0019373) | 2.55271481 |
128 | glycoprotein catabolic process (GO:0006516) | 2.54059862 |
129 | arginine metabolic process (GO:0006525) | 2.53095672 |
130 | short-chain fatty acid metabolic process (GO:0046459) | 2.53052750 |
131 | acetyl-CoA metabolic process (GO:0006084) | 2.52596556 |
132 | fatty acid transmembrane transport (GO:1902001) | 2.51993699 |
133 | lipid homeostasis (GO:0055088) | 2.51583421 |
134 | positive regulation of fatty acid oxidation (GO:0046321) | 2.50156489 |
135 | benzene-containing compound metabolic process (GO:0042537) | 2.49961591 |
136 | cholesterol transport (GO:0030301) | 2.49803134 |
137 | sterol transport (GO:0015918) | 2.49803134 |
138 | protein localization to endosome (GO:0036010) | 2.49519265 |
139 | protein activation cascade (GO:0072376) | 2.47240447 |
140 | macroautophagy (GO:0016236) | 2.47071642 |
141 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.46393584 |
142 | ovulation from ovarian follicle (GO:0001542) | 2.45394128 |
143 | retinal cone cell development (GO:0046549) | 2.44891077 |
144 | behavioral response to ethanol (GO:0048149) | 2.44672801 |
145 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.41720892 |
146 | kidney morphogenesis (GO:0060993) | 2.39648194 |
147 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.39286445 |
148 | positive regulation of phosphatase activity (GO:0010922) | 2.39099142 |
149 | regulation of energy homeostasis (GO:2000505) | 2.38128480 |
150 | regulation of pigment cell differentiation (GO:0050932) | 2.37746275 |
151 | cellular response to ethanol (GO:0071361) | 2.36526163 |
152 | pharyngeal system development (GO:0060037) | 2.35984671 |
153 | serotonin metabolic process (GO:0042428) | 2.34086799 |
154 | mesenchymal cell development (GO:0014031) | 2.34061144 |
155 | kidney mesenchyme development (GO:0072074) | 2.33793387 |
156 | neural tube formation (GO:0001841) | 2.33310024 |
157 | neuronal stem cell maintenance (GO:0097150) | 2.32287791 |
158 | atrial cardiac muscle cell action potential (GO:0086014) | 2.32217204 |
159 | regulation of sequestering of triglyceride (GO:0010889) | 2.31988780 |
160 | glomerular filtration (GO:0003094) | 2.31567466 |
161 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.31555563 |
162 | sulfation (GO:0051923) | 2.30989221 |
163 | magnesium ion transport (GO:0015693) | 2.30415830 |
164 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.29639880 |
165 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.29493092 |
166 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.29198706 |
167 | regulation of hippo signaling (GO:0035330) | 2.29049694 |
168 | embryonic axis specification (GO:0000578) | 2.28978235 |
169 | prostate gland growth (GO:0060736) | 2.28509418 |
170 | transmission of nerve impulse (GO:0019226) | 2.27749305 |
171 | N-glycan processing (GO:0006491) | 2.27291105 |
172 | cardiac ventricle morphogenesis (GO:0003208) | 2.27026689 |
173 | bicarbonate transport (GO:0015701) | 2.26533447 |
174 | regulation of DNA endoreduplication (GO:0032875) | 2.21252051 |
175 | nephron epithelium morphogenesis (GO:0072088) | 2.21027089 |
176 | nephron tubule morphogenesis (GO:0072078) | 2.21027089 |
177 | growth hormone receptor signaling pathway (GO:0060396) | 2.20559053 |
178 | nucleus localization (GO:0051647) | 2.20251746 |
179 | stem cell development (GO:0048864) | 2.19924190 |
180 | cyclic nucleotide metabolic process (GO:0009187) | 2.19232478 |
181 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.19191976 |
182 | indole-containing compound metabolic process (GO:0042430) | 2.18335264 |
183 | fucose catabolic process (GO:0019317) | 2.18267656 |
184 | L-fucose metabolic process (GO:0042354) | 2.18267656 |
185 | L-fucose catabolic process (GO:0042355) | 2.18267656 |
186 | alkaloid metabolic process (GO:0009820) | 2.15918411 |
187 | regulation of fatty acid oxidation (GO:0046320) | 2.15685952 |
188 | positive regulation of vascular permeability (GO:0043117) | 2.14896709 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.67334115 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.25479622 |
3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.78121717 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.53670527 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.96562253 |
6 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.68034746 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.55644837 |
8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.55176851 |
9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37594034 |
10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34245724 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.08727125 |
12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02630906 |
13 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88753797 |
14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.85432830 |
15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.83669534 |
16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82990552 |
17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81635312 |
18 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81133866 |
19 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76877698 |
20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76159508 |
21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75109361 |
22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.72454172 |
23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.71426193 |
24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68429763 |
25 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.67877719 |
26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60193665 |
27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.58900279 |
28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56886939 |
29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56338640 |
30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.55231055 |
31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54968446 |
32 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.54107108 |
33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53819326 |
34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.52651597 |
35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51064186 |
36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50591490 |
37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47551642 |
38 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46342938 |
39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45885396 |
40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45763515 |
41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45039127 |
42 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44591288 |
43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43135936 |
44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42150298 |
45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41548581 |
46 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40737816 |
47 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39895331 |
48 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.39892586 |
49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.38139165 |
50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36970497 |
51 | TCF4_23295773_ChIP-Seq_U87_Human | 1.35071592 |
52 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34450554 |
53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33243284 |
54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33041154 |
55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32785386 |
56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32785386 |
57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.31699264 |
58 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31492515 |
59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30869836 |
60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29144553 |
61 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29023892 |
62 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.27391136 |
63 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26768099 |
64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24856597 |
65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24856597 |
66 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22493986 |
67 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.21866681 |
68 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20876665 |
69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19881108 |
70 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19371910 |
71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.19209894 |
72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18853504 |
73 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18853358 |
74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18824251 |
75 | KDM2B_26808549_Chip-Seq_REH_Human | 1.18395927 |
76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17851127 |
77 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.17036059 |
78 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.16523106 |
79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16279682 |
80 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16001795 |
81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15752799 |
82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15666203 |
83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15281242 |
84 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14725052 |
85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14362994 |
86 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13341441 |
87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13209727 |
88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12758153 |
89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12400627 |
90 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.11898278 |
91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11415370 |
92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10665033 |
93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09805241 |
94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09345416 |
95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08785823 |
96 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08623413 |
97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.08216160 |
98 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08205990 |
99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07776240 |
100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07431170 |
101 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07431170 |
102 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06685806 |
103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06627197 |
104 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05601827 |
105 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05543294 |
106 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05166938 |
107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04968589 |
108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04068719 |
109 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03954284 |
110 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02929511 |
111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01415312 |
112 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01369955 |
113 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01159062 |
114 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00877363 |
115 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99751791 |
116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98975527 |
117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98915498 |
118 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.97961886 |
119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.97304253 |
120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.96541869 |
121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95734081 |
122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94697481 |
123 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.94477509 |
124 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.92867568 |
125 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92788297 |
126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91371016 |
127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90977809 |
128 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.90712144 |
129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90370657 |
130 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.89291215 |
131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88591836 |
132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88021842 |
133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87897281 |
134 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87800089 |
135 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87385093 |
136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87072453 |
137 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86564110 |
138 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.86484659 |
139 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84789137 |
140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84755078 |
141 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84736964 |
142 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84661066 |
143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.83791935 |
144 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83688013 |
145 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83400420 |
146 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83227883 |
147 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83223362 |
148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83186668 |
149 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83100026 |
150 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82653501 |
151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82284718 |
152 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.81665916 |
153 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81002160 |
154 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80695425 |
155 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79997161 |
156 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79418857 |
157 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78835240 |
158 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78602294 |
159 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78510671 |
160 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78495550 |
161 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78382644 |
162 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.78133921 |
163 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77684495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 6.16469741 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.04853940 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.84429948 |
4 | MP0005365_abnormal_bile_salt | 4.54457662 |
5 | MP0002009_preneoplasia | 4.22147196 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.77546679 |
7 | MP0003011_delayed_dark_adaptation | 3.71477504 |
8 | MP0003252_abnormal_bile_duct | 3.68704290 |
9 | MP0008877_abnormal_DNA_methylation | 3.60837024 |
10 | MP0010329_abnormal_lipoprotein_level | 3.18047911 |
11 | MP0001986_abnormal_taste_sensitivity | 2.92577217 |
12 | MP0005551_abnormal_eye_electrophysiolog | 2.49496037 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.49096646 |
14 | MP0003283_abnormal_digestive_organ | 2.44629303 |
15 | MP0010386_abnormal_urinary_bladder | 2.44472352 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.37942336 |
17 | MP0001501_abnormal_sleep_pattern | 2.36988480 |
18 | MP0010234_abnormal_vibrissa_follicle | 2.36104248 |
19 | MP0010368_abnormal_lymphatic_system | 2.29132468 |
20 | MP0003890_abnormal_embryonic-extraembry | 2.22971112 |
21 | MP0001666_abnormal_nutrient_absorption | 2.19078900 |
22 | MP0000427_abnormal_hair_cycle | 2.16019066 |
23 | MP0005167_abnormal_blood-brain_barrier | 2.11543175 |
24 | MP0005645_abnormal_hypothalamus_physiol | 2.10731895 |
25 | MP0009840_abnormal_foam_cell | 2.04580366 |
26 | MP0004043_abnormal_pH_regulation | 2.04545712 |
27 | MP0005083_abnormal_biliary_tract | 2.03252932 |
28 | MP0002138_abnormal_hepatobiliary_system | 1.93973008 |
29 | MP0004142_abnormal_muscle_tone | 1.84545892 |
30 | MP0000609_abnormal_liver_physiology | 1.83543257 |
31 | MP0002118_abnormal_lipid_homeostasis | 1.79017437 |
32 | MP0000013_abnormal_adipose_tissue | 1.76367412 |
33 | MP0004130_abnormal_muscle_cell | 1.74457157 |
34 | MP0004019_abnormal_vitamin_homeostasis | 1.71283622 |
35 | MP0005332_abnormal_amino_acid | 1.70886337 |
36 | MP0003300_gastrointestinal_ulcer | 1.70784089 |
37 | MP0001485_abnormal_pinna_reflex | 1.65346051 |
38 | MP0003787_abnormal_imprinting | 1.58193357 |
39 | MP0003136_yellow_coat_color | 1.57344730 |
40 | MP0000631_abnormal_neuroendocrine_gland | 1.54313901 |
41 | MP0001879_abnormal_lymphatic_vessel | 1.53093401 |
42 | MP0005174_abnormal_tail_pigmentation | 1.52406047 |
43 | MP0003690_abnormal_glial_cell | 1.47188447 |
44 | MP0000569_abnormal_digit_pigmentation | 1.46817713 |
45 | MP0002277_abnormal_respiratory_mucosa | 1.45896450 |
46 | MP0005595_abnormal_vascular_smooth | 1.44654937 |
47 | MP0005253_abnormal_eye_physiology | 1.44574759 |
48 | MP0003868_abnormal_feces_composition | 1.43905756 |
49 | MP0009046_muscle_twitch | 1.40126918 |
50 | MP0003183_abnormal_peptide_metabolism | 1.37391605 |
51 | MP0009745_abnormal_behavioral_response | 1.35606502 |
52 | MP0002090_abnormal_vision | 1.34967364 |
53 | MP0003195_calcinosis | 1.34587644 |
54 | MP0004484_altered_response_of | 1.29958836 |
55 | MP0002163_abnormal_gland_morphology | 1.26100268 |
56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26091194 |
57 | MP0002638_abnormal_pupillary_reflex | 1.23933551 |
58 | MP0005409_darkened_coat_color | 1.23411392 |
59 | MP0005319_abnormal_enzyme/_coenzyme | 1.22092973 |
60 | MP0002254_reproductive_system_inflammat | 1.21631923 |
61 | MP0010678_abnormal_skin_adnexa | 1.20190802 |
62 | MP0003806_abnormal_nucleotide_metabolis | 1.20189073 |
63 | MP0000604_amyloidosis | 1.20169880 |
64 | MP0003646_muscle_fatigue | 1.19635501 |
65 | MP0009764_decreased_sensitivity_to | 1.18833709 |
66 | MP0004883_abnormal_blood_vessel | 1.16279521 |
67 | MP0000647_abnormal_sebaceous_gland | 1.12767401 |
68 | MP0004924_abnormal_behavior | 1.11728010 |
69 | MP0005386_behavior/neurological_phenoty | 1.11728010 |
70 | MP0001324_abnormal_eye_pigmentation | 1.10898347 |
71 | MP0001440_abnormal_grooming_behavior | 1.08838086 |
72 | MP0003119_abnormal_digestive_system | 1.08306186 |
73 | MP0005623_abnormal_meninges_morphology | 1.08219004 |
74 | MP0003303_peritoneal_inflammation | 1.07976555 |
75 | MP0009780_abnormal_chondrocyte_physiolo | 1.06205546 |
76 | MP0000470_abnormal_stomach_morphology | 1.04808535 |
77 | MP0003075_altered_response_to | 1.04698714 |
78 | MP0005503_abnormal_tendon_morphology | 1.04251004 |
79 | MP0000538_abnormal_urinary_bladder | 1.03654520 |
80 | MP0005646_abnormal_pituitary_gland | 1.03275511 |
81 | MP0009697_abnormal_copulation | 1.02654052 |
82 | MP0004272_abnormal_basement_membrane | 1.02081303 |
83 | MP0004215_abnormal_myocardial_fiber | 1.01933604 |
84 | MP0005195_abnormal_posterior_eye | 1.01569221 |
85 | MP0002876_abnormal_thyroid_physiology | 1.00739792 |
86 | MP0002064_seizures | 0.99299047 |
87 | MP0009250_abnormal_appendicular_skeleto | 0.98059336 |
88 | MP0001764_abnormal_homeostasis | 0.96603321 |
89 | MP0002971_abnormal_brown_adipose | 0.96417689 |
90 | MP0000230_abnormal_systemic_arterial | 0.94977400 |
91 | MP0003045_fibrosis | 0.94790699 |
92 | MP0002067_abnormal_sensory_capabilities | 0.94636389 |
93 | MP0003950_abnormal_plasma_membrane | 0.92823723 |
94 | MP0002166_altered_tumor_susceptibility | 0.92664710 |
95 | MP0000762_abnormal_tongue_morphology | 0.92375288 |
96 | MP0005379_endocrine/exocrine_gland_phen | 0.92283705 |
97 | MP0005187_abnormal_penis_morphology | 0.91647119 |
98 | MP0001664_abnormal_digestion | 0.89726413 |
99 | MP0000598_abnormal_liver_morphology | 0.88948836 |
100 | MP0005166_decreased_susceptibility_to | 0.88843262 |
101 | MP0009763_increased_sensitivity_to | 0.86651032 |
102 | MP0002938_white_spotting | 0.86376524 |
103 | MP0008872_abnormal_physiological_respon | 0.85001111 |
104 | MP0004185_abnormal_adipocyte_glucose | 0.84809456 |
105 | MP0008961_abnormal_basal_metabolism | 0.84734487 |
106 | MP0002734_abnormal_mechanical_nocicepti | 0.83879188 |
107 | MP0002272_abnormal_nervous_system | 0.83761085 |
108 | MP0010307_abnormal_tumor_latency | 0.83758321 |
109 | MP0005666_abnormal_adipose_tissue | 0.82141537 |
110 | MP0002928_abnormal_bile_duct | 0.81767392 |
111 | MP0002006_tumorigenesis | 0.81611443 |
112 | MP0005620_abnormal_muscle_contractility | 0.81412538 |
113 | MP0005334_abnormal_fat_pad | 0.81056427 |
114 | MP0001502_abnormal_circadian_rhythm | 0.80198179 |
115 | MP0001756_abnormal_urination | 0.79882486 |
116 | MP0003959_abnormal_lean_body | 0.79511766 |
117 | MP0005535_abnormal_body_temperature | 0.78127174 |
118 | MP0005310_abnormal_salivary_gland | 0.78087698 |
119 | MP0009643_abnormal_urine_homeostasis | 0.77996046 |
120 | MP0004885_abnormal_endolymph | 0.76209244 |
121 | MP0000462_abnormal_digestive_system | 0.75943951 |
122 | MP0003937_abnormal_limbs/digits/tail_de | 0.75494108 |
123 | MP0005248_abnormal_Harderian_gland | 0.75416849 |
124 | MP0003632_abnormal_nervous_system | 0.75168136 |
125 | MP0004134_abnormal_chest_morphology | 0.74842380 |
126 | MP0003755_abnormal_palate_morphology | 0.73029815 |
127 | MP0010352_gastrointestinal_tract_polyps | 0.72219028 |
128 | MP0006054_spinal_hemorrhage | 0.71232427 |
129 | MP0002572_abnormal_emotion/affect_behav | 0.71159366 |
130 | MP0002693_abnormal_pancreas_physiology | 0.69339007 |
131 | MP0004270_analgesia | 0.67848348 |
132 | MP0009115_abnormal_fat_cell | 0.67782832 |
133 | MP0001486_abnormal_startle_reflex | 0.67592914 |
134 | MP0003656_abnormal_erythrocyte_physiolo | 0.67294254 |
135 | MP0004742_abnormal_vestibular_system | 0.66432959 |
136 | MP0003633_abnormal_nervous_system | 0.66427091 |
137 | MP0003091_abnormal_cell_migration | 0.65841577 |
138 | MP0002078_abnormal_glucose_homeostasis | 0.65724388 |
139 | MP0005389_reproductive_system_phenotype | 0.65606243 |
140 | MP0005391_vision/eye_phenotype | 0.65561629 |
141 | MP0003724_increased_susceptibility_to | 0.65425406 |
142 | MP0000249_abnormal_blood_vessel | 0.65077440 |
143 | MP0002063_abnormal_learning/memory/cond | 0.64621820 |
144 | MP0002168_other_aberrant_phenotype | 0.64453428 |
145 | MP0001661_extended_life_span | 0.64417843 |
146 | MP0005448_abnormal_energy_balance | 0.63543945 |
147 | MP0008469_abnormal_protein_level | 0.63144879 |
148 | MP0000383_abnormal_hair_follicle | 0.63134083 |
149 | MP0006072_abnormal_retinal_apoptosis | 0.62379167 |
150 | MP0005647_abnormal_sex_gland | 0.62223569 |
151 | MP0003329_amyloid_beta_deposits | 0.61929540 |
152 | MP0005464_abnormal_platelet_physiology | 0.61514456 |
153 | MP0000767_abnormal_smooth_muscle | 0.61215251 |
154 | MP0008874_decreased_physiological_sensi | 0.60925486 |
155 | MP0004264_abnormal_extraembryonic_tissu | 0.60614989 |
156 | MP0002332_abnormal_exercise_endurance | 0.60062427 |
157 | MP0002229_neurodegeneration | 0.59981830 |
158 | MP0009765_abnormal_xenobiotic_induced | 0.58996537 |
159 | MP0009384_cardiac_valve_regurgitation | 0.58096380 |
160 | MP0003943_abnormal_hepatobiliary_system | 0.57851650 |
161 | MP0005164_abnormal_response_to | 0.57400131 |
162 | MP0004782_abnormal_surfactant_physiolog | 0.57292531 |
163 | MP0005084_abnormal_gallbladder_morpholo | 0.56004601 |
164 | MP0005375_adipose_tissue_phenotype | 0.55683128 |
165 | MP0001915_intracranial_hemorrhage | 0.54012780 |
166 | MP0004947_skin_inflammation | 0.53956162 |
167 | MP0009642_abnormal_blood_homeostasis | 0.53699084 |
168 | MP0005376_homeostasis/metabolism_phenot | 0.53204635 |
169 | MP0003453_abnormal_keratinocyte_physiol | 0.53101316 |
170 | MP0002909_abnormal_adrenal_gland | 0.52295041 |
171 | MP0000465_gastrointestinal_hemorrhage | 0.52100600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.64830928 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.11865979 |
3 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.88355107 |
4 | Abnormality of alanine metabolism (HP:0010916) | 4.88355107 |
5 | Hyperalaninemia (HP:0003348) | 4.88355107 |
6 | Pigmentary retinal degeneration (HP:0001146) | 4.74632004 |
7 | Type II lissencephaly (HP:0007260) | 4.64703637 |
8 | Xanthomatosis (HP:0000991) | 4.54573471 |
9 | Complement deficiency (HP:0004431) | 4.50594918 |
10 | Cerebellar dysplasia (HP:0007033) | 4.44602218 |
11 | Hyperventilation (HP:0002883) | 4.37780485 |
12 | Large for gestational age (HP:0001520) | 4.36523941 |
13 | Hypobetalipoproteinemia (HP:0003563) | 4.31907505 |
14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.15623016 |
15 | Pheochromocytoma (HP:0002666) | 4.15363077 |
16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.09737189 |
17 | Hyperlipoproteinemia (HP:0010980) | 4.04961627 |
18 | Prolonged partial thromboplastin time (HP:0003645) | 3.87934841 |
19 | Congenital stationary night blindness (HP:0007642) | 3.86710759 |
20 | Abnormality of the pons (HP:0007361) | 3.83772707 |
21 | Chorioretinal atrophy (HP:0000533) | 3.83234127 |
22 | Epidermoid cyst (HP:0200040) | 3.71007426 |
23 | Central scotoma (HP:0000603) | 3.46231182 |
24 | Neuroendocrine neoplasm (HP:0100634) | 3.45823308 |
25 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.45750562 |
26 | Buphthalmos (HP:0000557) | 3.44576468 |
27 | Hypolipoproteinemia (HP:0010981) | 3.43177167 |
28 | Long nose (HP:0003189) | 3.33355916 |
29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.31337643 |
30 | * Abnormality of the common coagulation pathway (HP:0010990) | 3.23329130 |
31 | Joint hemorrhage (HP:0005261) | 3.14633054 |
32 | Hypoalphalipoproteinemia (HP:0003233) | 3.13940823 |
33 | Hypochromic microcytic anemia (HP:0004840) | 3.08294303 |
34 | Esophageal varix (HP:0002040) | 3.08115937 |
35 | Hypercholesterolemia (HP:0003124) | 3.06014032 |
36 | Hematochezia (HP:0002573) | 3.03680321 |
37 | Myocardial infarction (HP:0001658) | 3.01379946 |
38 | Abnormality of complement system (HP:0005339) | 2.97942017 |
39 | Hypoglycemic coma (HP:0001325) | 2.95933708 |
40 | Dyschromatopsia (HP:0007641) | 2.93330033 |
41 | Abnormality of macular pigmentation (HP:0008002) | 2.93067935 |
42 | Papillary thyroid carcinoma (HP:0002895) | 2.91957651 |
43 | Conjunctival hamartoma (HP:0100780) | 2.90875562 |
44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.90330865 |
45 | Lissencephaly (HP:0001339) | 2.90025789 |
46 | Abnormality of the vitreous humor (HP:0004327) | 2.89992874 |
47 | Hyperammonemia (HP:0001987) | 2.86241894 |
48 | Scotoma (HP:0000575) | 2.84916186 |
49 | Pancreatic cysts (HP:0001737) | 2.83224130 |
50 | Furrowed tongue (HP:0000221) | 2.78893823 |
51 | Meningioma (HP:0002858) | 2.78762929 |
52 | Duplicated collecting system (HP:0000081) | 2.77243477 |
53 | Fat malabsorption (HP:0002630) | 2.76534268 |
54 | Hypoplasia of the pons (HP:0012110) | 2.75895136 |
55 | Concave nail (HP:0001598) | 2.75837048 |
56 | Ketosis (HP:0001946) | 2.71414982 |
57 | Stomach cancer (HP:0012126) | 2.70461006 |
58 | Bone cyst (HP:0012062) | 2.69151939 |
59 | Abnormality of the intrinsic pathway (HP:0010989) | 2.68842736 |
60 | Fair hair (HP:0002286) | 2.67907343 |
61 | Prominent supraorbital ridges (HP:0000336) | 2.63638530 |
62 | Hypoplastic ischia (HP:0003175) | 2.63336556 |
63 | Congenital, generalized hypertrichosis (HP:0004540) | 2.62494652 |
64 | Cone-rod dystrophy (HP:0000548) | 2.60790277 |
65 | Hepatocellular carcinoma (HP:0001402) | 2.59907930 |
66 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58479336 |
67 | Skin nodule (HP:0200036) | 2.56602114 |
68 | Abnormality of the ischium (HP:0003174) | 2.56301881 |
69 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.56018393 |
70 | Polydipsia (HP:0001959) | 2.55580647 |
71 | Abnormal drinking behavior (HP:0030082) | 2.55580647 |
72 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.50553394 |
73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.50543059 |
74 | Abolished electroretinogram (ERG) (HP:0000550) | 2.46540662 |
75 | Abnormality of the renal medulla (HP:0100957) | 2.46123733 |
76 | Abnormality of the renal collecting system (HP:0004742) | 2.45751008 |
77 | Hamartoma of the eye (HP:0010568) | 2.45256406 |
78 | Acanthocytosis (HP:0001927) | 2.42533585 |
79 | Macular degeneration (HP:0000608) | 2.40480707 |
80 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.38898253 |
81 | Decreased circulating renin level (HP:0003351) | 2.38275953 |
82 | Pancreatic fibrosis (HP:0100732) | 2.37587222 |
83 | Spastic diplegia (HP:0001264) | 2.33741617 |
84 | Short hallux (HP:0010109) | 2.33083795 |
85 | Protruding tongue (HP:0010808) | 2.33025809 |
86 | Tubular atrophy (HP:0000092) | 2.32949029 |
87 | Macroorchidism (HP:0000053) | 2.32873896 |
88 | True hermaphroditism (HP:0010459) | 2.32733781 |
89 | Generalized hypopigmentation of hair (HP:0011358) | 2.30867987 |
90 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29784492 |
91 | Hemiparesis (HP:0001269) | 2.29208465 |
92 | Retinal dysplasia (HP:0007973) | 2.27433332 |
93 | Spontaneous abortion (HP:0005268) | 2.27063595 |
94 | Spontaneous hematomas (HP:0007420) | 2.26095975 |
95 | Polycythemia (HP:0001901) | 2.25890575 |
96 | Hyperglycinemia (HP:0002154) | 2.21318140 |
97 | Glomerulonephritis (HP:0000099) | 2.19399546 |
98 | Non-midline cleft lip (HP:0100335) | 2.19028099 |
99 | Abnormality of the nasal septum (HP:0000419) | 2.18109732 |
100 | Vitreoretinal degeneration (HP:0000655) | 2.17567925 |
101 | Mitral stenosis (HP:0001718) | 2.16809280 |
102 | Hypoglycemic seizures (HP:0002173) | 2.16200900 |
103 | Hemiplegia (HP:0002301) | 2.14478224 |
104 | Nephronophthisis (HP:0000090) | 2.14243326 |
105 | Systemic lupus erythematosus (HP:0002725) | 2.13501844 |
106 | Hemorrhage of the eye (HP:0011885) | 2.13486833 |
107 | Amyloidosis (HP:0011034) | 2.11185689 |
108 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.10395029 |
109 | Thyroid carcinoma (HP:0002890) | 2.09884511 |
110 | Abnormality of midbrain morphology (HP:0002418) | 2.09509636 |
111 | Molar tooth sign on MRI (HP:0002419) | 2.09509636 |
112 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.08144052 |
113 | Abnormality of glycine metabolism (HP:0010895) | 2.08144052 |
114 | Hemangiomatosis (HP:0007461) | 2.06836723 |
115 | Visceral angiomatosis (HP:0100761) | 2.06417831 |
116 | Limb dystonia (HP:0002451) | 2.06190298 |
117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04782088 |
118 | Hamartoma (HP:0010566) | 2.03907636 |
119 | Subacute progressive viral hepatitis (HP:0006572) | 2.03893683 |
120 | Febrile seizures (HP:0002373) | 2.01375844 |
121 | Renal tubular acidosis (HP:0001947) | 2.01191937 |
122 | Lymphangioma (HP:0100764) | 1.99501784 |
123 | Posterior subcapsular cataract (HP:0007787) | 1.99409287 |
124 | Hyperkalemia (HP:0002153) | 1.98199712 |
125 | Thrombophlebitis (HP:0004418) | 1.97570535 |
126 | Gingival bleeding (HP:0000225) | 1.97356090 |
127 | Gaze-evoked nystagmus (HP:0000640) | 1.96997321 |
128 | Anterior segment dysgenesis (HP:0007700) | 1.95915967 |
129 | Subcapsular cataract (HP:0000523) | 1.95207708 |
130 | Macroglossia (HP:0000158) | 1.94516925 |
131 | Abnormality of the renal cortex (HP:0011035) | 1.93294036 |
132 | Abnormality of the 2nd finger (HP:0004100) | 1.92995228 |
133 | Depressed nasal tip (HP:0000437) | 1.92747651 |
134 | Pulmonary embolism (HP:0002204) | 1.92667407 |
135 | Partial agenesis of the corpus callosum (HP:0001338) | 1.92451738 |
136 | Widely spaced teeth (HP:0000687) | 1.92451413 |
137 | Overgrowth (HP:0001548) | 1.91062948 |
138 | Nephritis (HP:0000123) | 1.90874717 |
139 | Ketoacidosis (HP:0001993) | 1.90722641 |
140 | Hyperglycinuria (HP:0003108) | 1.90356400 |
141 | Conjunctival telangiectasia (HP:0000524) | 1.89456965 |
142 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.88135369 |
143 | Abnormality of purine metabolism (HP:0004352) | 1.87499866 |
144 | Polyuria (HP:0000103) | 1.85083272 |
145 | Retinal atrophy (HP:0001105) | 1.83148122 |
146 | Exotropia (HP:0000577) | 1.83120427 |
147 | Sensorimotor neuropathy (HP:0007141) | 1.82876355 |
148 | Abnormality of the parietal bone (HP:0002696) | 1.82655577 |
149 | Goiter (HP:0000853) | 1.81776936 |
150 | Vascular calcification (HP:0004934) | 1.81588348 |
151 | Broad-based gait (HP:0002136) | 1.81466374 |
152 | Abnormality of methionine metabolism (HP:0010901) | 1.80734941 |
153 | Decreased central vision (HP:0007663) | 1.80376098 |
154 | Intention tremor (HP:0002080) | 1.80317447 |
155 | Abnormal biliary tract morphology (HP:0012440) | 1.80119039 |
156 | Mesangial abnormality (HP:0001966) | 1.79849117 |
157 | Vertebral arch anomaly (HP:0008438) | 1.79483844 |
158 | Progressive visual loss (HP:0000529) | 1.79000099 |
159 | Increased CSF protein (HP:0002922) | 1.77324123 |
160 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.76298242 |
161 | Type II diabetes mellitus (HP:0005978) | 1.75973683 |
162 | Amelogenesis imperfecta (HP:0000705) | 1.74971265 |
163 | Cardiovascular calcification (HP:0011915) | 1.74935753 |
164 | Poor head control (HP:0002421) | 1.74380415 |
165 | Hypomagnesemia (HP:0002917) | 1.74024559 |
166 | Steatorrhea (HP:0002570) | 1.72539827 |
167 | Hyperbilirubinemia (HP:0002904) | 1.72382101 |
168 | Abnormality of nucleobase metabolism (HP:0010932) | 1.71783324 |
169 | Poikilocytosis (HP:0004447) | 1.71674202 |
170 | Focal segmental glomerulosclerosis (HP:0000097) | 1.71092462 |
171 | Absent/shortened dynein arms (HP:0200106) | 1.70998798 |
172 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.70998798 |
173 | Severe muscular hypotonia (HP:0006829) | 1.70591457 |
174 | Hypoplastic nipples (HP:0002557) | 1.69315272 |
175 | Clumsiness (HP:0002312) | 1.67530999 |
176 | Tachypnea (HP:0002789) | 1.67375757 |
177 | Stroke (HP:0001297) | 1.67226864 |
178 | Mitral valve prolapse (HP:0001634) | 1.65954797 |
179 | Rib fusion (HP:0000902) | 1.65673867 |
180 | Progressive inability to walk (HP:0002505) | 1.65230694 |
181 | Turricephaly (HP:0000262) | 1.65088324 |
182 | Abnormal pancreas size (HP:0012094) | 1.64903260 |
183 | Glomerulosclerosis (HP:0000096) | 1.64588116 |
184 | Tetraplegia (HP:0002445) | 1.64006504 |
185 | Hoarse voice (HP:0001609) | 1.63847096 |
186 | Autoimmune thrombocytopenia (HP:0001973) | 1.63284791 |
187 | Upper motor neuron abnormality (HP:0002127) | 1.62785749 |
188 | Attenuation of retinal blood vessels (HP:0007843) | 1.62202825 |
189 | Cerebral hemorrhage (HP:0001342) | 1.62092053 |
190 | Neoplasm of the thyroid gland (HP:0100031) | 1.59550666 |
191 | Neoplasm of the adrenal gland (HP:0100631) | 1.59315785 |
192 | Inability to walk (HP:0002540) | 1.58100442 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 3.10266969 |
2 | CASK | 3.07704282 |
3 | FGFR2 | 3.07157633 |
4 | ACVR1B | 2.95810242 |
5 | FGFR4 | 2.88648733 |
6 | TIE1 | 2.85726627 |
7 | WNK4 | 2.49712135 |
8 | LATS1 | 2.44928341 |
9 | SIK1 | 2.35610875 |
10 | RIPK1 | 2.34274965 |
11 | STK39 | 2.17865138 |
12 | GRK1 | 2.14218847 |
13 | PTK6 | 2.08122460 |
14 | FGFR3 | 2.02086410 |
15 | CAMK1G | 1.98225096 |
16 | ERN1 | 1.97074909 |
17 | MKNK2 | 1.96169511 |
18 | CAMK1D | 1.96039047 |
19 | YES1 | 1.91443606 |
20 | TGFBR2 | 1.89914080 |
21 | PDGFRA | 1.88812467 |
22 | ZAK | 1.87224893 |
23 | STK38L | 1.85110611 |
24 | BMPR1B | 1.84721413 |
25 | ADRBK2 | 1.80818728 |
26 | NTRK3 | 1.71088569 |
27 | PKN2 | 1.70752062 |
28 | JAK1 | 1.68182353 |
29 | MAP3K10 | 1.62239199 |
30 | MAP3K12 | 1.60921107 |
31 | PNCK | 1.59990703 |
32 | TRIB3 | 1.50215039 |
33 | MAP2K4 | 1.49181517 |
34 | TAOK3 | 1.44710835 |
35 | EPHB1 | 1.43433316 |
36 | INSRR | 1.43038259 |
37 | OXSR1 | 1.43026446 |
38 | CAMKK2 | 1.39896211 |
39 | TNIK | 1.39384046 |
40 | RIPK4 | 1.38159345 |
41 | MAP3K2 | 1.36428167 |
42 | AKT3 | 1.36392751 |
43 | RET | 1.36082171 |
44 | TYK2 | 1.32083370 |
45 | WNK3 | 1.26726275 |
46 | TAF1 | 1.24392323 |
47 | SIK2 | 1.22974683 |
48 | MUSK | 1.21828093 |
49 | PIK3CA | 1.21445015 |
50 | PDGFRB | 1.19901052 |
51 | JAK2 | 1.19499449 |
52 | CDK6 | 1.18490855 |
53 | SCYL2 | 1.17058622 |
54 | TRPM7 | 1.16181872 |
55 | MAP3K13 | 1.11872123 |
56 | MARK1 | 1.11496290 |
57 | MAP3K7 | 1.11153279 |
58 | CHUK | 1.10911564 |
59 | TYRO3 | 1.08436332 |
60 | DMPK | 1.08307518 |
61 | NLK | 1.04269615 |
62 | ERBB2 | 1.01216954 |
63 | PRKCH | 1.00950635 |
64 | KDR | 0.99967007 |
65 | KSR1 | 0.98934580 |
66 | TGFBR1 | 0.98263457 |
67 | MAP3K14 | 0.97968712 |
68 | SGK3 | 0.94456433 |
69 | DAPK2 | 0.92668564 |
70 | PTK2B | 0.92043169 |
71 | STK24 | 0.91828326 |
72 | ADRBK1 | 0.87389380 |
73 | PRKCE | 0.87281916 |
74 | MAPK15 | 0.85149579 |
75 | MAPK13 | 0.81858252 |
76 | ERBB4 | 0.81547744 |
77 | FER | 0.79437474 |
78 | KSR2 | 0.79200736 |
79 | PHKG1 | 0.78437838 |
80 | PHKG2 | 0.78437838 |
81 | TLK1 | 0.78432722 |
82 | WNK1 | 0.77518219 |
83 | NEK9 | 0.77317474 |
84 | PRKAA2 | 0.77273665 |
85 | PDK1 | 0.76967277 |
86 | PDPK1 | 0.76455052 |
87 | MST1R | 0.76062552 |
88 | NEK6 | 0.75723016 |
89 | CDK12 | 0.72449868 |
90 | JAK3 | 0.71954810 |
91 | STK3 | 0.71745929 |
92 | CSK | 0.71481440 |
93 | EGFR | 0.70474955 |
94 | IRAK3 | 0.68206055 |
95 | FGFR1 | 0.67687213 |
96 | MAP3K4 | 0.67236046 |
97 | OBSCN | 0.67118490 |
98 | PINK1 | 0.66986916 |
99 | BMX | 0.66278229 |
100 | BRSK2 | 0.66104453 |
101 | CAMKK1 | 0.65624197 |
102 | GSK3A | 0.65231942 |
103 | NUAK1 | 0.64436443 |
104 | MKNK1 | 0.64401633 |
105 | CSNK1A1L | 0.63979439 |
106 | NTRK1 | 0.63792067 |
107 | MAPK12 | 0.62773184 |
108 | FLT3 | 0.62529395 |
109 | PRKD1 | 0.61278279 |
110 | LMTK2 | 0.60792549 |
111 | TBK1 | 0.59986471 |
112 | PAK2 | 0.59874332 |
113 | MAPK11 | 0.59609271 |
114 | PAK3 | 0.58988146 |
115 | SGK2 | 0.58930247 |
116 | CSF1R | 0.58610109 |
117 | MAPK7 | 0.57191447 |
118 | ERBB3 | 0.57097072 |
119 | STK38 | 0.57020772 |
120 | ITK | 0.56861913 |
121 | PTK2 | 0.55534451 |
122 | HIPK2 | 0.54824369 |
123 | STK11 | 0.54338570 |
124 | PRKCZ | 0.54123280 |
125 | ABL1 | 0.53825429 |
126 | IRAK1 | 0.53579033 |
127 | BCKDK | 0.53514148 |
128 | CSNK1G2 | 0.53127854 |
129 | IGF1R | 0.52206454 |
130 | PRKCQ | 0.51320150 |
131 | MAP2K1 | 0.51270277 |
132 | RPS6KA6 | 0.50861019 |
133 | PIM1 | 0.50838694 |
134 | MARK3 | 0.50494480 |
135 | STK10 | 0.50488839 |
136 | CAMK2A | 0.48847805 |
137 | FYN | 0.48531461 |
138 | LRRK2 | 0.47749866 |
139 | INSR | 0.47549650 |
140 | IKBKB | 0.47496418 |
141 | PRKACG | 0.47468624 |
142 | MAP2K6 | 0.47412834 |
143 | SGK1 | 0.46899260 |
144 | MAP3K1 | 0.46799315 |
145 | ROCK1 | 0.45006443 |
146 | EPHB2 | 0.44958872 |
147 | PRKAA1 | 0.44533173 |
148 | CSNK1G1 | 0.44315901 |
149 | NTRK2 | 0.44169115 |
150 | PAK6 | 0.43246003 |
151 | MAP3K9 | 0.43012550 |
152 | CSNK1D | 0.42793064 |
153 | MET | 0.42557919 |
154 | EPHA3 | 0.41892704 |
155 | MTOR | 0.41892680 |
156 | DYRK1B | 0.41490584 |
157 | SGK223 | 0.40277744 |
158 | SGK494 | 0.40277744 |
159 | PLK2 | 0.40023264 |
160 | RPS6KA2 | 0.36036669 |
161 | MELK | 0.35731948 |
162 | PRKG1 | 0.34091665 |
163 | FGR | 0.32642903 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.12009809 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.53959345 |
3 | Phototransduction_Homo sapiens_hsa04744 | 3.00990093 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98184519 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78946924 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44409739 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.40911071 |
8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.40547517 |
9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.17736540 |
10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11370345 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03500494 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00658069 |
13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.98495636 |
14 | Bile secretion_Homo sapiens_hsa04976 | 1.82230195 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77440924 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77172003 |
17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73218483 |
18 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.67943016 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.67146918 |
20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56027036 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52637102 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48424855 |
23 | Mineral absorption_Homo sapiens_hsa04978 | 1.46612970 |
24 | ABC transporters_Homo sapiens_hsa02010 | 1.46439408 |
25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45800737 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44165655 |
27 | Long-term depression_Homo sapiens_hsa04730 | 1.39883199 |
28 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.37006686 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.34052533 |
30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30875333 |
31 | Peroxisome_Homo sapiens_hsa04146 | 1.30282142 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.29617322 |
33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29521955 |
34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.28413007 |
35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25466820 |
36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25028360 |
37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22922060 |
38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.20855652 |
39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.19813508 |
40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14712823 |
41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14228703 |
42 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13046214 |
43 | Morphine addiction_Homo sapiens_hsa05032 | 1.12734926 |
44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.10434148 |
45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.09172715 |
46 | Lysine degradation_Homo sapiens_hsa00310 | 1.08189526 |
47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.06524085 |
48 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.03974872 |
49 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.03737688 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00807937 |
51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97294918 |
52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96958234 |
53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.96302298 |
54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96231912 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94347029 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93076850 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90280740 |
58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.87303986 |
59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87076607 |
60 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86262479 |
61 | Insulin resistance_Homo sapiens_hsa04931 | 0.85856263 |
62 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.85103474 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83895616 |
64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83674582 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82083407 |
66 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80445565 |
67 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.79488030 |
68 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77421320 |
69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77035715 |
70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76708166 |
71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75643001 |
72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75515304 |
73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74999418 |
74 | Tight junction_Homo sapiens_hsa04530 | 0.74966625 |
75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73579661 |
76 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71284716 |
77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70714795 |
78 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.70169530 |
79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68351628 |
80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67782598 |
81 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67533323 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66886530 |
83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66080899 |
84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66045750 |
85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65733950 |
86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64524561 |
87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62873100 |
88 | Taste transduction_Homo sapiens_hsa04742 | 0.61665788 |
89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61534369 |
90 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.60481329 |
91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59868873 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59759544 |
93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59295180 |
94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58551511 |
95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.57062236 |
96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55899774 |
97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54945117 |
98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54252043 |
99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54071782 |
100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53156945 |
101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52578413 |
102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52135802 |
103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50562968 |
104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49634448 |
105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48087139 |
106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47139734 |
107 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.46362226 |
108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45857799 |
109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45663784 |
110 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44950413 |
111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44487553 |
112 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43823055 |
113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41736489 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.40916501 |
115 | Amoebiasis_Homo sapiens_hsa05146 | 0.38699151 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36958693 |
117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35859810 |
118 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35023346 |
119 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34964554 |
120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33565893 |
121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32405416 |
122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31859661 |
123 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31573150 |
124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30938772 |
125 | Glioma_Homo sapiens_hsa05214 | 0.30639991 |
126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30032860 |
127 | Renin secretion_Homo sapiens_hsa04924 | 0.29634496 |
128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29248919 |
129 | Adherens junction_Homo sapiens_hsa04520 | 0.29240323 |
130 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.29015890 |
131 | Platelet activation_Homo sapiens_hsa04611 | 0.28492955 |
132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.26911462 |
133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26900312 |
134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26768474 |
135 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.26676369 |
136 | Hepatitis C_Homo sapiens_hsa05160 | 0.26116174 |
137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25374506 |
138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25372487 |
139 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25176303 |
140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24433493 |
141 | Salivary secretion_Homo sapiens_hsa04970 | 0.23958613 |
142 | * Focal adhesion_Homo sapiens_hsa04510 | 0.23430267 |
143 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.23255917 |
144 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.21304691 |
145 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.21152005 |
146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20707335 |
147 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.20634891 |
148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20477848 |
149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19770101 |
150 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19726058 |
151 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19343013 |
152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18550972 |
153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18297119 |
154 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.18078100 |
155 | Circadian entrainment_Homo sapiens_hsa04713 | 0.17852513 |
156 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17614038 |